Physician profile
Angela Kay Wright
NPI 1598316564
$3,101.92
in general payments reported to CMS, 2019-2025
22 companies · $660 in 2025
The $660 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $307 · 2022: $454 · 2023: $855 · 2024: $826 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,303 · Education: $37.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,302.74 |
| Education | $37.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,808.78 | 2021-2025 | |
| Lilly USA, LLC | $250.34 | 2021-2025 | Mounjaro, Trulicity |
| Novo Nordisk INC | $217.45 | 2022-2025 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.94 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $111.24 | 2021-2025 | Breztri |
| Amgen INC. | $105.12 | 2021-2022 | |
| Viatris Specialty LLC | $42.81 | 2025 | Yupelri |
| Exact Sciences Corporation | $41.34 | 2023-2024 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $40.78 | 2021 | |
| Abbott Laboratories | $40.49 | 2024-2025 | Freestyle Libre 3 |
| Optinose US, INC. | $38.80 | 2024 | |
| Sumitomo Pharma America, INC. | $34.18 | 2023-2025 | Gemtesa |
| Amarin Pharma, INC. | $23.66 | 2021 | |
| Tactile Systems Technology INC | $22.61 | 2025 | Flexitouch Plus, Nimbl |
| Exeltis, USA INC. | $22.35 | 2023 | Slynd |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $19.62 | 2023 | Auvelity |
| Merck Sharp & Dohme LLC | $19.30 | 2022 | |
| Rgh Enterprises LLC | $18.07 | 2025 | |
| Verona Pharma, INC. | $14.95 | 2025 | Ohtuvayre |
| Advanced Respiratory, INC | $14.46 | 2021 | |
| Astellas Pharma US INC | $13.63 | 2023 | Veozah |
| Pfizer INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.